EUROFINS CEREP |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21,800 EUR | -0.91% |
|
-0.91% | -12.80% |
| 2023 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2022 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
| Sales 2021 | 41.63M 44.31M | Sales 2022 | 47.65M 50.72M | Capitalization | 112M 119M |
|---|---|---|---|---|---|
| Net income 2021 | 9M 9.58M | Net income 2022 | 11M 11.71M | EV / Sales 2021 | 2.05 x |
| Net cash position 2021 | 1.28M 1.36M | Net cash position 2022 | 12.81M 13.63M | EV / Sales 2022 | 2.08 x |
| P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | 209 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 4.22% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | -0.91% | ||
| 1 week | -0.91% | ||
| Current month | -5.22% | ||
| 1 month | -5.22% | ||
| 3 months | -12.80% | ||
| 6 months | -16.79% | ||
| Current year | -12.80% |
1 week
21 800.00
22 000.00
1 month
21 800.0023 000.00
Current year
21 800.0025 000.00
1 year
21 800.0029 200.00
3 years
13 100.0029 200.00
5 years
4 620.0029 200.00
10 years
4 300.0029 200.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 18-04-18 | |
Damien Séroux
CHM | Chairman | - | 14-10-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Damien Séroux
CHM | Chairman | - | 14-10-12 |
| Director/Board Member | 68 | 15-06-09 | |
| Chief Executive Officer | - | 18-04-18 |
| Date | Price | Change |
|---|---|---|
| 24-04-18 | 21,800 | 0.00% |
| 24-04-17 | 21,800 | 0.00% |
| 24-04-16 | 21,800 | 0.00% |
| 24-04-15 | 21,800 | -0.91% |
| 24-04-12 | 22,000 | 0.00% |
Real-time Euronext Paris, April 15, 2024 at 10:30 am EDT
More quotes
Eurofins Cerep (formerly Eurofins-Cerep) specializes in the pre-clinical research of drugs for the pharmaceutical industry.
Exports account for 97.9% of net sales.
Calendar
2024-05-22
- Shareholders Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -12.80% | 117M | |
| -1.82% | 41.36B | |
| +44.25% | 41.3B | |
| +2.56% | 39.61B | |
| -12.11% | 25.62B | |
| +3.09% | 24.09B | |
| -24.16% | 18.38B | |
| +22.12% | 11.85B | |
| -3.74% | 11.82B | |
| +7.75% | 11.07B |
- Stock Market
- Equities
- ALECR Stock
